ArticleRenal failure2026
Dose-response relationship between physical activity and sarcopenia in peritoneal dialysis patients.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Physical activity (PA) is of great importance for peritoneal dialysis (PD) patients with sarcopenia. However, the optimal PA dose for sarcopenia in PD patients remains unclear. This study adopted a cross-sectional design and enrolled PD patients from two large general hospitals in China between March 2023 and February 2025. Sarcopenia was diagnosed in accordance with the 2019 criteria of the Asian Working Group for Sarcopenia. The Chinese Low Physical Activity Questionnaire was used to assess PA levels. Restricted cubic spline (RCS) models were applied to examine the dose-response relationships of total PA consumption, total walking time, leisure walking time, light physical activity time, and inactive time with sarcopenia and its three parameters in PD patients. A total of 881 participants were included in the final analysis. Non-linear dose-response relationships were observed between total PA consumption and the prevalence of sarcopenia (overall
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.